Ebalzotan (developmental code name NAE-086) is a selective 5-HT1A receptor agonist. It was under development as an antidepressant and anxiolytic agent but produced undesirable side effects in phase I clinical trials and was subsequently discontinued.
Ebalzotan (developmental code name NAE-086) is a selective 5-HT1A receptor agonist. It was under development as an antidepressant and anxiolytic agent but produced undesirable side effects in phase I clinical trials and was subsequently discontinued.
Source: Wikipedia "Ebalzotan" · CC BY-SA 4.0
Share this article: X · Bluesky